Empowering appropriate antimicrobial use with rapid diagnostics.

Rapid Testing

By testing patients and providing results quickly, antibiotics can be withheld and antivirals can be prescribed only where appropriate. Physician awareness of a rapid diagnosis of influenza decreases antibiotic use.1 Traditional diagnosis of influenza by viral culture or polymerase chain reaction (PCR) is too lengthy to be useful in generating treatment options.1 

Alere i Influenza A & B

Alere™ i Influenza A & B is a brand new molecular flu test which provides accurate results in less than 15 minutes on the Alere™ i platform. Significantly faster than other molecular methods and more accurate than conventional rapid testing, Alere™ i Influenza A & B enables you to deliver actionable flu results to your patients in any setting and empowers the appropriate use of antibiotics and antivirals. 

Alere™ i Influenza A & B NOW CLIA WAIVED!

Find out more at Alere-i.com

Alere also offers a range of lateral flow tests to aid in the rapid diagnosis of flu, including Alere BinaxNOW®, Clearview® and SD; all excellent tools for determining those who require treatment.